An analysis of sex differences in the genetics of schizophrenia, bipolar disorder and major depressive disorders indicates that while there is substantial genetic overlap between males and females, there are noticeable sex-dependent differences in how genes related to the central…
Read More
Study provides insights into architecture of abnormal protein deposits in brain disorders
Scientists at the Case Western Reserve University School of Medicine have determined the structure of protein “fibrils” linked to Lou Gehrig’s disease and other neurodegenerative disorders—findings that provide clues to how toxic proteins clump and spread between nerve cells in…
Read More
Bio-based membranes with ocular stem cells to treat corneal disorders
The production, preparation, and use of bacterial nanocellulose as corneal bandages could be the key to help delicate stem cells to migrate to the cornea and heal the eye from a range of ocular disorders. Our eyes have a very…
Read More
Testosterone nasal spray to treat anxiety disorders
A testosterone-containing nasal spray received its second U.S. patent and its first patent in Europe, making it the first testosterone therapy licensed to treat anxiety disorders. Although testosterone therapy is most often marketed and prescribed to men suffering from “low…
Read More
Comorbid psychiatric disorders explain increased risk for self-harm in autism spectrum disorders
A population-based study revealed reasons behind elevated suicide risk, attempted suicides, and other selfharm, which require special health care, among a and young adults with autism spectrum disorders. Comorbid disorders, especially non-affective psychoses and the affective and anxiety disorders, explained…
Read More
Luby honored for advancing understanding of brain, behavior disorders
Joan L. Luby, MD, the Samuel and Mae S. Ludwig Professor of Psychiatry at Washington University School of Medicine in St. Louis, has received the Ruane Prize for Child & Adolescent Psychiatry from the Brain & Behavior Research Foundation. The…
Read More
Cognitive Disorders More Common in People Admitted for COVID-19
WEDNESDAY, Nov. 4, 2020 — Alzheimer disease and dementia are risk factors for hospital admission due to COVID-19, according to a study published online Oct. 24 in Brain, Behavior, and Immunity. Jingqi Zhou, Ph.D., from the University of Georgia in…
Read More
Research finds links between COVID-19 and neuromuscular disorders
A literature review by a University at Buffalo researcher reveals two noteworthy findings related to COVID-19 and patients with neuromuscular disorders. The research shows that the novel coronavirus can bring on neuromuscular conditions in patients who previously had none, and…
Read More
Supporting children with developmental disorders during COVID-19
Departure from routine can be especially hard for children with developmental disorders, and the changes to daily life wrought by the pandemic pose an extra challenge for them and for their families. Yale’s Dr. Fred Volkmar, a leading authority on…
Read More
Computer guided drug delivery developed for brain disorders
While we are starting to get a handle on drugs and therapeutics that might to help alleviate brain disorders, efficient delivery remains a roadblock to tackling these devastating diseases. New research from the Graybiel, Cima, and Langer labs at MIT…
Read More